# Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS

> **NCT07328425** · PHASE2 · RECRUITING · sponsor: **Italian Sarcoma Group** · enrollment: 20 (estimated)

## Conditions studied

- Desmoplastic Small Round Cell Tumor

## Interventions

- **DRUG:** Lurbinectedin
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT07328425
- **Lead sponsor:** Italian Sarcoma Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-21
- **Primary completion:** 2030-10-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07328425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07328425, "Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07328425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*